PCOS (Polycystic Ovary Syndrome) - Medical Reference¶
Historical Context and Medical Evolution¶
The Stein-Leventhal Era (1935-1980s)¶
Polycystic ovary syndrome was first formally described in 1935 when Irving Stein and Michael Leventhal reported on a group of women presenting with amenorrhea (absent menstruation), infertility, hirsutism (excess hair growth), and enlarged ovaries containing multiple cysts. The syndrome that bore their names—Stein-Leventhal Syndrome—was initially understood primarily as a surgical disease.
The treatment Stein and Leventhal proposed was ovarian wedge resection: surgically removing a portion of each ovary to reduce hormone production and restore ovulation. This approach, while often temporarily effective, was invasive and carried significant risks including adhesions that could further impair fertility. For decades, surgical intervention remained the primary treatment option.
Understanding of PCOS during this era focused narrowly on the reproductive system. The metabolic implications—insulin resistance, increased cardiovascular risk, long-term diabetes risk—were not yet recognized. Women with PCOS were treated for infertility and menstrual irregularity without understanding the syndrome's broader health implications.
Expanding Understanding (1980s-1990s)¶
The 1980s brought recognition that PCOS was more than a reproductive disorder. Researchers identified the connection between PCOS and insulin resistance, discovering that many women with PCOS had elevated insulin levels and impaired glucose metabolism regardless of body weight. This metabolic dimension transformed understanding of the syndrome from a purely gynecological condition to a systemic endocrine disorder.
The introduction of transvaginal ultrasound allowed visualization of polycystic ovarian morphology—the characteristic "string of pearls" appearance of multiple small follicles arranged around the ovarian periphery. This imaging capability enabled diagnosis without surgery and revealed that polycystic ovaries were far more common than previously recognized.
In 1990, the National Institutes of Health (NIH) convened the first consensus conference to establish standardized diagnostic criteria. The NIH criteria required both hyperandrogenism (clinical or biochemical signs of elevated androgens) AND chronic anovulation (irregular or absent ovulation), with exclusion of other causes. This definition, while providing needed standardization, was criticized for being too narrow and excluding women with milder presentations.
The Rotterdam Revolution (2003)¶
In 2003, twenty-seven PCOS experts met in Rotterdam, Netherlands, at a conference sponsored by the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM). The resulting "Rotterdam criteria" fundamentally expanded the diagnostic framework.
The Rotterdam criteria required only two of three features for diagnosis: 1. Oligo-ovulation or anovulation (irregular or absent periods) 2. Clinical and/or biochemical signs of hyperandrogenism (acne, hirsutism, elevated testosterone) 3. Polycystic ovaries on ultrasound (12+ follicles per ovary or increased ovarian volume)
This broader definition acknowledged the heterogeneity of PCOS presentations. A woman could now be diagnosed with PCOS even without the classic symptoms Stein and Leventhal described, recognizing that the syndrome existed on a spectrum. The Rotterdam criteria remain the most widely used diagnostic framework internationally.
Treatment Evolution¶
Oral Contraceptives became first-line treatment for managing menstrual irregularity and hyperandrogenism symptoms (acne, hirsutism). By suppressing ovarian androgen production and providing regular withdrawal bleeds, hormonal contraception addressed symptoms while preventing endometrial hyperplasia from unopposed estrogen.
Metformin, originally developed for type 2 diabetes, emerged as a transformative PCOS treatment in the 1990s-2000s. Studies demonstrated that metformin improved insulin sensitivity, reduced androgen levels, and could restore menstrual regularity and ovulation in many women with PCOS. For women desiring pregnancy, metformin offered an alternative or adjunct to traditional ovulation induction.
Clomiphene citrate remained the standard first-line ovulation induction agent for decades. However, studies in the 2010s demonstrated that letrozole (an aromatase inhibitor) achieved higher live birth rates in women with PCOS, leading to its adoption as preferred first-line therapy for ovulation induction.
Lifestyle modification—diet, exercise, and weight management—gained recognition as foundational PCOS treatment, with even modest weight loss (5-10%) significantly improving metabolic and reproductive parameters in overweight women.
Ongoing Challenges¶
Despite advances, PCOS remains underdiagnosed and undertreated. Many women experience years of symptoms before receiving diagnosis. The syndrome's heterogeneous presentation means some women don't fit stereotypical expectations (not all women with PCOS are overweight; not all have visible hirsutism). Diagnostic delays are particularly common in adolescents, where irregular periods may be dismissed as "normal" for young women.
The psychological burden of PCOS—body image concerns, fertility anxiety, depression, and anxiety—has gained increasing recognition but often remains inadequately addressed in clinical care.
Era-Specific Implications for Dr. Ayana Brooks¶
*Dr. Ayana Renée Brooks* (diagnosed with PCOS in adulthood) received her diagnosis in an era of sophisticated understanding—Rotterdam criteria, recognition of metabolic implications, multiple treatment options including metformin. As an OB/GYN, she understood the condition intimately, having guided countless patients through PCOS management and fertility challenges.
Yet medical knowledge couldn't eliminate the emotional weight of the diagnosis. She knew the statistics: women with PCOS often require medical intervention to conceive. She made peace with potential childlessness, channeling maternal energy into patient care rather than pursuing aggressive fertility treatments without the right partner.
Her unexpected natural pregnancy at age 38—without any fertility intervention, following Elliot Landry's chemotherapy—defied the statistical odds her training had taught her to cite. Women with PCOS can and do conceive naturally, but the combination of her PCOS, her age (advanced maternal age by obstetric standards), and Elliot's post-chemotherapy status made the positive pregnancy test feel medically improbable.
The pregnancy that followed was high-risk precisely because of her PCOS: increased risk of gestational diabetes, pre-eclampsia, and pregnancy complications compounded by twin gestation and maternal age. Her medical knowledge meant she understood every risk factor, every warning sign, every complication she was statistically more likely to face. The severe hyperemesis gravidarum that followed was one of those complications—potentially related to the hormonal storm of twin pregnancy in a body with underlying endocrine dysfunction.
Overview¶
Polycystic Ovary Syndrome (PCOS) is a hormonal disorder affecting the ovaries and overall endocrine function. The condition is characterized by irregular or absent ovulation, elevated androgen (testosterone) levels, and often the presence of multiple small cysts on the ovaries. PCOS affects approximately 1 in 10 women of reproductive age and is one of the leading causes of female infertility.
Common symptoms include irregular or absent menstrual periods, difficulty conceiving due to infrequent or absent ovulation, elevated testosterone causing acne or excess body hair, insulin resistance increasing diabetes risk, and weight management challenges. Not all people with PCOS experience all symptoms—presentation varies significantly.
PCOS is a lifelong condition with no cure, but symptoms can be managed through various interventions including hormonal birth control to regulate cycles, metformin for insulin resistance management, lifestyle modifications including diet and exercise, and fertility treatments when pregnancy is desired.
Representation in Canon¶
Dr. Ayana Renée Brooks was diagnosed with PCOS in adulthood. Throughout her adult life, doctors told her she would likely need medical intervention to conceive—IVF, fertility treatments, carefully timed ovulation induction. The consistent message was that natural conception would be difficult or impossible.
As an OB/GYN herself, Ayana understood the statistics intimately. She'd guided countless patients with PCOS through fertility journeys, explained the challenges with clinical clarity, reassured women that needing help to conceive didn't diminish their worth or womanhood. But applying that compassion to herself proved harder.
She made peace with the possibility that biological motherhood might not happen. She poured maternal instincts into caring for patients and their babies, celebrated others' pregnancies while privately grieving children she thought she'd never have. She didn't pursue fertility treatments—partly because the right partner hadn't appeared, partly because accepting childlessness felt easier than fighting her body's apparent refusal to cooperate.
The Unexpected Pregnancy:
At age 38, shortly after Elliot Landry completed 14 months of chemotherapy for low-grade glioma, Ayana discovered she was naturally pregnant—without any fertility intervention. Given her PCOS diagnosis, her age, and Elliot's post-chemotherapy status (which typically impacts fertility), the positive pregnancy test felt medically impossible even as it stared back at her.
Standing in her bathroom with the digital test reading "PREGNANT," Ayana called Jazmine Landry (Elliot's mother, staying with them during Elliot's recovery) and whispered, "It's positive." Her body, which medical professionals had told her wouldn't conceive naturally, had somehow said yes—not just to one life, but to twins.
The pregnancy represented both miracle and medical high-risk crisis. Ayana's PCOS contributed to increased risks during pregnancy including higher rates of gestational diabetes, pre-eclampsia, and pregnancy complications. Her twin pregnancy at age 38 with underlying PCOS created compounding risk factors requiring intensive medical management.
Daily Impact and Management¶
For Ayana pre-pregnancy, PCOS management involved understanding her body's patterns (or lack thereof), managing hormonal fluctuations, and making peace with fertility limitations. As a physician, she had access to medical management options but chose not to pursue aggressive fertility treatments without a partner and clear desire for biological children.
The PCOS diagnosis shaped her relationship with her body—understanding it as simultaneously capable (delivering other people's babies professionally) and apparently unable (to create her own pregnancy naturally). This duality required emotional processing and grief work that she largely did privately.
Post-pregnancy, Ayana's PCOS remains an ongoing condition. The unexpected natural conception didn't "cure" PCOS—it was a statistical anomaly, not a reversal of her diagnosis. She continues managing the condition while now also navigating motherhood to twins.
Emotional and Psychological Context¶
Ayana's PCOS diagnosis carried grief she rarely voiced. As an OB/GYN, she witnessed daily the births she facilitated for others—joyful moments she celebrated professionally while privately mourning the motherhood she believed her body would deny her. She became skilled at compartmentalizing, at holding space for others' fertility journeys without centering her own pain.
The unexpected pregnancy at age 38 brought complicated emotions: shock that her body had done what doctors said it couldn't, fear that something this improbable might not sustain, guilt about feeling terror alongside gratitude, and grief that even this "miracle" came with severe complications (hyperemesis gravidarum, pre-eclampsia warnings) rather than the healthy pregnancy she'd imagined in younger years.
When Ayana told Jazmine about the pregnancy, trembling on her bathroom floor, she added through tears: "I think there's more than one." Her body's extreme symptoms felt like twin pregnancy before any scan confirmed it—and being right about that added layers to her processing. Her PCOS body hadn't just conceived naturally; it had created two lives simultaneously.
Related Entries¶
Related Entries: Dr. Ayana Brooks; Elliot Landry; Hyperemesis Gravidarum (HG) - Medical Reference; Ariana Landry; Adrian Landry